- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06700252
Effects of Vestibular Rehabilitation in the Treatment of Dizziness and Balance Disturbances After Concussion
November 19, 2024 updated by: Beth Marschner
The goal of this clinical trial is to study the effects of including vestibular rehabilitation in the treatment of dizziness and balance disturbances in athletes after concussion. The main questions it aims to answer are:
- Does inclusion of vestibular rehabilitation treatment have an effect on symptom resolution in those with concussion?
- Does inclusion of vestibular rehabilitation treatment have an effect on the rate of recovery and return to play after concussion? Researchers will compare vestibular rehabilitation treatment inclusion in concussion treatment to a traditional concussion treatment approach to see if the rate of symptom resolution and return to play are affected by including vestibular rehabilitation for participants who have experienced a concussion within one week of presenting for the study.
Participants will:
- Be randomly assigned to either receive vestibular rehabilitation included in their concussion treatment or have traditional concussion treatment without vestibular rehabilitation.
- Complete treatment sessions two times per week for up to four weeks
- Complete the corresponding home program for the treatment group
- Complete baseline symptom testing and repeat the symptom testing at study completion for data comparison. Testing includes: Sport Concussion Assessment Tool (SCAT5) including 1) the athlete's background 2) symptom evaluation 3) cognitive screening 4) neurological screening and 5) delayed recall, a Dynamic Gait Index (DGI) including 1) gait on level surface 2) change in gait speed 3) gait with horizontal head turns 4) gait with vertical head turns 5) gait and pivot turn 6) step over obstacle 7) step around obstacle 8) stairs, and a vestibular evaluation including 1) patient history 2) visual assessment 3) vertebral artery clearance 4) cervical spine clearance 5) inner ear assessment 6) brief balance assessment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Nothing further to include that is not entered or uploaded elsewhere in the record
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Dakota
-
Minot, North Dakota, United States, 58707
- Minot State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Athlete from a small regional university
- Experiences a concussion
- Identified by their certified athletic trainer to have dizziness or balance dysfunctions
- Referred for initial contact testing and treatment
Exclusion Criteria:
- Acute spinal cord injury with neurological deficits
- Epidural and subdural hematoma with known manifestations
- Acute cervical spine injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vestibular Rehabilitation
This arm of the study received the vestibular rehabilitation treatment in addition to following traditional protocol.
|
This intervention used gaze stabilization, habituation, balance training and exertional training.
Exercises utilized included visual tracking, gaze holding with head turns, saccades, visual accommodation exercises, visual convergence exercises, positional accommodation, rockerboard proprioception, single leg balance on the floor and on dynamic surfaces, tandem balance on the floor and on dynamic surfaces, double leg balance on dynamic surfaces, mirror feedback of functional activities, and physical exertion training with walking, biking or sport specific activities.
|
|
Active Comparator: Traditional Treatment
This arm of the study received the traditional protocol in a stepwise progression only.
|
This intervention symptom management and graduated return to physical activity involving a stepwise progression in which the participant proceeded to the next step if symptom-free at the current step for a 24-hour period.
If any symptoms occurred at that step, the participant was returned to the previous step and tried to progress again after 24 hours of rest.
The steps were as follows: 1) Patient to return to regular activities such as school 2) Light aerobic activity to increase the patient's heart rate achieved with 5 to 10 minutes on a stationary bike or walking but without weightlifting 3) Moderate activity which increased the heart rate with head or body movement that may have included sport specific exercise with minimal-moderate resistance 4) Heavy, non-contact activity in three planes of movement 5) Full contact practice 6) Competition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dynamic Gait Index
Time Frame: Up to 4 weeks
|
The Dynamic Gait Index (DGI) includes 1) gait on level surface 2) change in gait speed 3) gait with horizontal head turns 4) gait with vertical head turns 5) gait and pivot turn 6) step over obstacle 7) step around obstacle 8) stairs.
Each item is scored on a four-point ordinal scale, ranging from 0-3. "0" indicates the lowest level of function, severe impairment and "3" indicates the highest level of function, normal.
There are a total of 24 possible points.
The lower the score out of 24, the more balance difficulties.
|
Up to 4 weeks
|
|
Sport Concussion Assessment Tool 5
Time Frame: Up to 4 weeks
|
The Sport Concussion Assessment Tool 5 includes: athlete's background, symptom evaluation, cognitive screening, neurological screening, and delayed recall.
The symptom scale is from 0 (none) to 6 (severe).
There are 22 symptoms with a max score of 132.
The higher the score, the more severe.
The cognitive screening includes 5 orientation questions, immediate memory using recall of 5 word lists, concentration tasks of backward digit recall starting with three digits and progressing to more if able, recalling the months of the year in reverse and delayed recall at the end of the assessment for the immediate memory word list again.
The neurological screening assesses reflexes, pupil response and motor function.
Balance is examined using the modified balance error scoring system where more errors indicates more balance issues.
|
Up to 4 weeks
|
|
Oculomotor Assessment
Time Frame: Up to 4 weeks
|
Oculomotor Assessment is used to evaluate eye movement and function to determine if movement and function are normal or abnormal.
This includes: smooth pursuits, horizontal saccades, vertical saccades, convergence, vestibulo-ocular reflex (VOR), and visual motion sensitivity Test (VMS).
|
Up to 4 weeks
|
|
Semicircular Canal Assessment
Time Frame: Up to 4 weeks
|
Semicircular Canal Assessment is used to evaluate how well the inner ear's semicircular canals detect head movement.
Tests included in this were the Hallpike-Dix for assessing the posterior canal and the Roll Test for assessing the horizontal canal.
|
Up to 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Beth Marschner, DPT, Minot State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 25, 2022
Primary Completion (Actual)
February 28, 2023
Study Completion (Actual)
February 28, 2023
Study Registration Dates
First Submitted
September 19, 2024
First Submitted That Met QC Criteria
November 19, 2024
First Posted (Estimated)
November 21, 2024
Study Record Updates
Last Update Posted (Estimated)
November 21, 2024
Last Update Submitted That Met QC Criteria
November 19, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2133 (European Union Funding for Research and Innovation - HORIZON 2020)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The individual participant data is not the main focus of the study.
The overall findings of the study with the larger number of participants to look at the trend is what will be shared (presented or published).
The IRB proposal for this study included confidentiality of each individual participant as that will be maintained, but the global findings are what will be shared after data analysis for comparison.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Concussion
-
Sync-Think, Inc.CompletedBrain Injuries | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion; Eye | Concussion, CerebralUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.United States Department of DefenseCompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
-
University Hospital, ToulouseTerminated
-
Thomas Jefferson UniversityRothman Institute OrthopaedicsTerminated
-
University of PittsburghWithdrawnConcussionUnited States
-
Sport Injury Prevention Research CentreUnknown
-
Children's Hospital Medical Center, CincinnatiCompleted
-
BrainScope Company, Inc.CompletedBrain Injuries, Traumatic | Concussion, Mild | Concussion, Brain | Concussion, Severe | Concussion, IntermediateUnited States
Clinical Trials on Vestibular Rehabilitation
-
Abant Izzet Baysal UniversityRecruitingMeniere DiseaseTurkey (Türkiye)
-
Oregon Health and Science UniversityPortland VA Medical CenterCompletedBrain InjuryUnited States
-
National Cheng Kung UniversityRecruiting
-
Maria Jesus Casuso-HolgadoWithdrawnQuality of Life | Multiple Sclerosis | Fatigue | Dizziness | Vestibular Disease | Usability | Balance Disorders | CybersicknessSpain
-
Ege UniversityTHE SCİENTİFİC AND TECHNOLOGİCAL RESEARCH COUNCİL OF TURKEY (TUBITAK)CompletedVestibular MigraineTurkey (Türkiye)
-
Ankara City Hospital BilkentCompletedVestibular Diseases | Vestibular Disorder | Vestibular VertigoTurkey
-
University of British ColumbiaRecruitingLabyrinthitis | Benign Paroxysmal Positional Vertigo | Vestibular Neuronitis | Meniere Disease | Vestibular Neuritis | Herpes Zoster Oticus | Peripheral Vestibular DisorderCanada
-
Ege UniversityCompletedVestibular Disorder | Peripheral Vestibular DisorderTurkey
-
Boston Children's HospitalCompletedVestibular DiseasesUnited States